The recent appointment of DMC Atlanta president Adam Dorfman to the Australian-based Movember Foundation National Advisory Council reflects the direct marketing and sales firm’s continuing advocacy of the foundation’s work in support of prostate and testicular cancer patients.
In his eight years of leading this effort, DMC Atlanta has raised more than $175,000 for Movember. Last year, Dorfman was Movember’s second-highest individual fundraiser in the U.S., and third internationally.
DMC Atlanta raised more than $61,000 in November to support the foundation, it announced in a press release. This was reported to be the eighth-highest team total in the U.S..
The Movember Foundation, which funds men’s health initiatives around the world, has raised $837 million since its 2003 inception.
“As a member of the Movember Foundation’s National Advisory Council, I’m well aware of the impact our fundraising makes,” Dorfman said. “And I’m incredibly proud of the work of the DMC Atlanta team this year. Our team truly supports Movember’s mission to help men get the physical and emotional help they need to live longer, happier, healthier lives.”
By 2030, the foundation’s goal is to cut in half the number of men dying from prostate cancer worldwide, and halve those facing serious ongoing side effects from prostate cancer treatment. The disease kills more than 30,000 men in the United States annually, according to the American Cancer Society. The foundation aims to reduce the number of men dying prematurely, by whatever cause, by 25 percent.
Last year’s DMC Atlanta’s fundraisers included the third annual rare whisky dinner, a bowling tournament, yoga class, and T-shirt sales. Men on the team grew mustaches as part of Movember’s “Grow a Mo, Save a Bro” fundraising campaign.
In 2017, the last year for which totals are available, the foundation raised $17.1 million in the U.S. With campaigns such as Move for Movember and Host a Mo-Ment, it has funded more than 1,200 men’s health projects worldwide.
The foundation is raising awareness about prostate cancer by helping men understand the signs, symptoms and risk factors. Movember is also working with researchers to learn more about the most lethal tumors, and how to slow disease progression. It also hopes to reduce treatment side effects and increase access to patient services and support.
Movember is looking to governments to provide affordable prostate cancer treatments and to get new therapies approved quickly. It supports customized treatment and precision care, and getting patients the accurate information needed to make informed treatment decisions.
In hopes of reducing the number of patients who aren’t getting the best outcomes, Movember works to identify excellence in prostate cancer treatment and care by investing in global projects. Its Global Action Plan (GAP), for example, is an international research initiative that brings investigators together to tackle some of the toughest challenges for prostate and testicular cancer patients. Since its 2011 launch, the GAP has formed seven global initiatives supporting 350 researchers from 90 institutions across 20 countries.
For more information, here is a link to Movember’s many health initiatives.